AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glifit-M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Fitwel Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glifit-M 1 Tablet SR

Metformin-Glimepiride 1mg/1mg extended-release tablet is an antidiabetic medication combining two agents for adult type 2 diabetes management. It regulates blood glucose levels. This medication should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical advice can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's part of a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize its symptoms (sweating, dizziness, headache, tremors) and how to manage them. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are advised.

Primary Ingredients of Glifit-M 1 Tablet SR

No text provided. Please provide the text you wish me to rewrite.

Uses of Glifit-M 1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glifit-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Glifit-M 1 Tablet SR with food.

Common Side effects of Glifit-M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glifit-M 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Glifit-M 1 Tablet SR with a meal.

How Glifit-M 1 Tablet SR works:

Glifit-M SR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glifit-M 1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glifit-M 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

The extended-release Glifit-M tablet (1mg) is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glifit-M 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glifit-M 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glifit-M 1 Tablet SR to individuals with hepatic impairment. Dosage modification of Glifit-M 1 Tablet SR may be necessary. Physician consultation is advised. A reduced initial dose of Glifit-M 1 Tablet SR is typically recommended for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe liver disease.

What if you forget to take Glifit-M 1 Tablet SR :

Should you forget a Glifit-M 1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glifit-M 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glifit-M 1 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glifit-M 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glifit-M 1 Tablet SR and seek immediate medical attention.
Glifit-M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glifit-M 1 Tablet SR may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Glifit-M 1 Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glifit-M 1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glifit-M 1 Tablet SR and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glifit-M 1 Tablet SR
49
MRP 60
18% off